Infectious Disease Alert – November 1, 2002

November 1, 2002

• Infectious Disease

  In this feature, brief items, primarily gleaned from abstracts or articles in journals and other resources not commonly perused by most US infectious disease physicians, will be presented, usually without comment.

  Read more

• Pharmacology Watch: High-Dose Rofecoxib Confirmed Prothrombotic, Study Shows

  High-Dose Rofecoxib Confirmed Prothrombotic, Study Shows; Losartan Better Than Atenolol for LVH Treatment; Lisinopril, Not Losartan, Improves Myocardial Perfusion; New Fluoroquinolone Study; Warfarin After MI Better Than Aspirin Alone; FDA News

  Read more

• Clinical Briefs in Primary Care Supplement

  Read more